Meanwhile Goldman Sachs weighing in with upgraded forecasts:
GS citing the output loss at Vale due to the tragic dam collapse
Most Popular
Sponsored
EMR's P/S, P/E, P/B high; NDSN mixed valuation; SWK low P/S, P/B, high 4.1% yield.
TRN's Q1 revenue missed estimates, but margins expanded on cost cuts. Outlook positive despite backlog dip.
BDC beats Q1 estimates, guides higher, but stock dips on acquisition news. Valuation concerns loom.
Nvidia's AI boosts quantum computing accuracy 3x, eyeing huge future returns. Early mover advantage.
WCC beats revenue/profit estimates! Data center sales surge 70%, outlook raised. Buy now?
Atrium Health & WakeMed eye $2B merger, boosting NC healthcare jobs. Awaiting approval.
KEX beats Q1 revenue & EPS estimates. Strong marine demand & backlog, but watch fuel costs & engine delays.
Sponsored
Must Read
